Diana Shipping Highlights ISS & Glass Lewis Support in Hostile Bid for Genco at $24.80/Share
GNK sits 86% above its 52-week low of $12.835.
Summary
Diana Shipping updated its tender offer for Genco, highlighting proxy advisor recommendations that support its hostile takeover bid and oppose Genco's defensive poison pill.
Key Events · M&A and Partnerships · GNK
-
Tender Offer Update
Diana Shipping's subsidiary, 4 Dragon Merger Sub Inc., is offering to acquire Genco's outstanding shares for $24.80 per share in cash. This represents a premium to the current stock price of $23.87.
-
Proxy Advisor Support
Institutional Shareholder Services (ISS) recommended Genco shareholders vote AGAINST the ratification of Genco's poison pill, citing entrenchment concerns. Glass Lewis also noted the pill could limit shareholders' ability to evaluate Diana's offer.
-
Board Nominee Push
Diana urges shareholders to vote for its two independent director nominees, Jens Ismar and Paul Cornell, and to withhold votes for two incumbent Genco directors at the upcoming June 18, 2026, Annual Meeting.
-
Offer Expiration
The all-cash tender offer is set to expire at 5:00 p.m. New York City time on June 26, 2026, unless further extended.
Analysis · GNK · Energy & Transportation
This filing updates Diana Shipping's hostile tender offer for Genco, emphasizing proxy advisor support against Genco's poison pill and for Diana's board nominees. The $24.80 per share all-cash offer represents a premium to Genco's current trading price. With the annual meeting and tender offer expiration approaching, this update intensifies pressure on Genco's board to engage or risk shareholder dissent, potentially leading to a change in control or a revised offer.
At the time of this filing, GNK was trading at $23.87 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $1B. The 52-week trading range was $12.84 to $27.25. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.